News

Cipla introduces HUENA, a non-antibiotic treatment for recurrent urinary tract infections (UTIs) in India. Reduces antibiotic ...
Drug firm Cipla on Friday said it has introduced a non-antibiotic treatment for patients suffering from recurrent urinary ...
American Urological Association Release Recurrent Uncomplicated Urinary Tract Infections in Women Guideline Amendment Today, ...
At the early signs, try over-the-counter products such as Cystopurin or D-Mannose. Eating kefir can also help with recurrent ...
Regulators have given a new antibiotic the green light to treat urinary tract infections (UTIs) for the first time in almost ...
Monsoon season increases the risk of urinary tract infections (UTIs) in women due to excess moisture and poor hygiene. Learn how to prevent, spot, and manage UTIs.
Drug firm Cipla on Friday said it has introduced a non-antibiotic treatment for patients suffering from recurrent urinary tract infections.The company has launched Methenamine Hippurate under the ...
Gepotidacin, also known as Blujepa, can be used by women who suffer recurring infections, the Medicines and Healthcare products Regulatory Agency said. | ITV National News ...
Julian Beach, MHRA Interim Executive Director, Healthcare Quality and Access, said: “As the first new type of oral antibiotic ...
Gepotidacin, also known as Blujepa, can be used by women in the UK who suffer recurring infections, the MHRA said.
Investing.com -- GSK plc (LON:GSK) has received U.K. regulatory approval for its oral antibiotic treatment for uncomplicated urinary tract infections (UTIs), marking the first new type of oral ...
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval to GSK's oral antibiotic pill, ...